TREATMENT AND SURVIVAL PATTERNS IN RELATION TO MULTIMORBIDITY IN PATIENTS WITH LOCOREGIONAL BREAST AND COLORECTAL CANCER

Overview

Journal J Geriatr Oncol

Publisher Elsevier

Specialty Geriatrics

Date 2011 Jul 26

PMID 21785664

Citations 12

Authors

Siran M Koroukian

Paul M Bakaki

Mark D Schluchter

Cynthia Owusu

Affiliations

Soon will be listed here.

Abstract

PURPOSE: To examine the effects of the occurrence and co-occurrence of comorbidities (COM), functional limitations (FL), and geriatric syndromes (GS) on treatment and outcomes in older cancer patients. MATERIALS AND METHODS: We used records from the Ohio Cancer Incidence Surveillance System linked with Medicare data, clinical assessment data from the home health care Outcomes and Assessment Information Set, and death certificate data. Our patient population included fee-for-service HHC Medicare beneficiaries diagnosed with incident loco-regional breast or colorectal cancer in years 1999-2001 (n=1236). We grouped patients according to the presence of multimorbidity: (0): none of COM, FL, or GS; (1): occurrence - but no co-occurrence - of COM, FL, or GS; (2): co-occurrence of any two of COM, FL, and GS; and (3): co-occurrence of all three of COM, FL, and GS. Our outcomes were receipt of standard treatment, as well as overall survival (OS) and disease-specific survival (DSS) through 2005. Multivariable regression models were developed to analyze the independent association between multimorbidity and the outcomes, before and after adjusting for age. RESULTS: The effect of multimorbidity on our outcomes was attenuated considerably by age. Adjusting for age and compared with no multimorbidity (0), high multimorbidity (3) remained significantly and negatively associated with receipt of standard treatment (adjusted odds ratio: 0.57, 95% Confidence Interval (CI): 0.33, 0.97). Furthermore, high multimorbidity (3) was associated with increased hazard for OS, but not for DSS (adjusted hazard ratio and 95% CI: 2.15 (1.58, 2.93) for three entities). CONCLUSION: Multimorbidity is significantly and independently associated with cancer treatment and OS, but not DSS.

Citing Articles

Multimorbidity and Complexity Among Patients with Cancer in Ontario: A Retrospective Cohort Study Exploring the Clustering of 17 Chronic Conditions with Cancer.

Kone A, Scharf D, Tan A Cancer Control. 2023; 30:10732748221150393.

PMID: 36631419 PMC: 9841838. DOI: 10.1177/10732748221150393.

Physical Comorbidities and Their Relationship with Cancer Treatment and Its Outcomes in Older Adult Populations: Systematic Review.

George M, Smith A, Sabesan S, Ranmuthugala G JMIR Cancer. 2021; 7(4):e26425.

PMID: 34643534 PMC: 8552093. DOI: 10.2196/26425.

Prevalence of multimorbidity in adults with cancer, and associated health service utilization in Ontario, Canada: a population-based retrospective cohort study.

Kone A, Scharf D BMC Cancer. 2021; 21(1):406.

PMID: 33853565 PMC: 8048167. DOI: 10.1186/s12885-021-08102-1.

Examination of individual and multiple comorbid conditions and health-related quality of life in older cancer survivors.

Siembida E, Smith A, Potosky A, Graves K, Jensen R Qual Life Res. 2021; 30(4):1119-1129.

PMID: 33447956 PMC: 7808400. DOI: 10.1007/s11136-020-02713-0.

The multimorbidity profile of South African women newly diagnosed with breast cancer.

Ayeni O, Norris S, Joffe M, Cubasch H, Nietz S, Buccimazza I Int J Cancer. 2019; 147(2):361-374.

PMID: 31600408 PMC: 7649092. DOI: 10.1002/ijc.32727.

References

Rao A, Seo P, Cohen H . Geriatric assessment and comorbidity. Semin Oncol. 2004; 31(2):149-59. DOI: 10.1053/j.seminoncol.2003.12.026. View

Madigan E, Fortinsky R . Interrater reliability of the outcomes and assessment information set: results from the field. Gerontologist. 2004; 44(5):689-92. DOI: 10.1093/geront/44.5.689. View

Satariano W, Silliman R . Comorbidity: implications for research and practice in geriatric oncology. Crit Rev Oncol Hematol. 2003; 48(2):239-48. DOI: 10.1016/j.critrevonc.2003.08.002. View

Koroukian S, Murray P, Madigan E . Comorbidity, disability, and geriatric syndromes in elderly cancer patients receiving home health care. J Clin Oncol. 2006; 24(15):2304-10. DOI: 10.1200/JCO.2005.03.1567. View

Koroukian S, Scharpf T, Bakaki P, Madigan E . Identifying comorbidities in home health care patients: does the Outcome and Assessment Information Set have incremental value to Medicare claims data?. Home Health Care Serv Q. 2011; 30(1):1-9. DOI: 10.1080/01621424.2011.545726. View

Given B, Given C . Older adults and cancer treatment. Cancer. 2008; 113(12 Suppl):3505-11. PMC: 2606910. DOI: 10.1002/cncr.23939. View

Hurria A, Lachs M, Cohen H, Muss H, Kornblith A . Geriatric assessment for oncologists: rationale and future directions. Crit Rev Oncol Hematol. 2006; 59(3):211-7. DOI: 10.1016/j.critrevonc.2006.03.007. View

YATES J . Comorbidity considerations in geriatric oncology research. CA Cancer J Clin. 2002; 51(6):329-36. DOI: 10.3322/canjclin.51.6.329. View

Brown J, Vittinghoff E, Lin F, Nyberg L, Kusek J, Kanaya A . Prevalence and risk factors for urinary incontinence in women with type 2 diabetes and impaired fasting glucose: findings from the National Health and Nutrition Examination Survey (NHANES) 2001-2002. Diabetes Care. 2006; 29(6):1307-12. PMC: 1557358. DOI: 10.2337/dc05-2463. View

10.

Koroukian S . Assessment and interpretation of comorbidity burden in older adults with cancer. J Am Geriatr Soc. 2010; 57 Suppl 2:S275-8. PMC: 3199146. DOI: 10.1111/j.1532-5415.2009.02511.x. View

11.

Koroukian S, Xu F, Beaird H, Diaz M, Murray P, Rose J . Complexity of care needs and unstaged cancer in elders: a population-based study. Cancer Detect Prev. 2007; 31(3):199-206. PMC: 2577170. DOI: 10.1016/j.cdp.2007.04.002. View

12.

Balducci L, Beghe C . The application of the principles of geriatrics to the management of the older person with cancer. Crit Rev Oncol Hematol. 2000; 35(3):147-54. DOI: 10.1016/s1040-8428(00)00089-5. View

13.

Yancik R, Wesley M, Ries L, Havlik R, Long S, Edwards B . Comorbidity and age as predictors of risk for early mortality of male and female colon carcinoma patients: a population-based study. Cancer. 1998; 82(11):2123-34. View

14.

Blaum C, Ofstedal M, Liang J . Low cognitive performance, comorbid disease, and task-specific disability: findings from a nationally representative survey. J Gerontol A Biol Sci Med Sci. 2002; 57(8):M523-31. DOI: 10.1093/gerona/57.8.m523. View

15.

Koroukian S, Xu F, Bakaki P, Diaz-Insua M, Towe T, Owusu C . Comorbidities, functional limitations, and geriatric syndromes in relation to treatment and survival patterns among elders with colorectal cancer. J Gerontol A Biol Sci Med Sci. 2009; 65(3):322-9. PMC: 2904594. DOI: 10.1093/gerona/glp180. View

16.

Jackson R, Vittinghoff E, Kanaya A, Miles T, Resnick H, Kritchevsky S . Urinary incontinence in elderly women: findings from the Health, Aging, and Body Composition Study. Obstet Gynecol. 2004; 104(2):301-7. DOI: 10.1097/01.AOG.0000133482.20685.d1. View

17.

Mehta K, Yaffe K, Covinsky K . Cognitive impairment, depressive symptoms, and functional decline in older people. J Am Geriatr Soc. 2002; 50(6):1045-50. PMC: 2939718. DOI: 10.1046/j.1532-5415.2002.50259.x. View

18.

Koroukian S . Linking the Ohio Cancer Incidence Surveillance System with Medicare, Medicaid, and Clinical Data from Home Health Care and Long Term Care Assessment Instruments: Paving the Way for New Research Endeavors in Geriatric Oncology. J Registry Manag. 2014; 35(4):156-165. PMC: 4131237. View

19.

Extermann M, Aapro M, Bernabei R, Cohen H, Droz J, Lichtman S . Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). Crit Rev Oncol Hematol. 2005; 55(3):241-52. DOI: 10.1016/j.critrevonc.2005.06.003. View

20.

Balducci L . Aging, frailty, and chemotherapy. Cancer Control. 2007; 14(1):7-12. DOI: 10.1177/107327480701400102. View